CARA   $0.3518  -0.90% Market Closed

Cara Therapeutics Inc
Total Cash 56.62M
totalCashPerShare 1.032
EBITDA -104.72M
Total Debt 47.16M
quickRatio 4.204
currentRatio 4.594
Total Revenue 11.00M
debtToEquity 406.656
Revenue/Share 0.202
ROA -0.63432
ROE -1.84321
grossProfits
freeCashflow -47.50M
operatingCashflow -79.91M
earningsGrowth
revenueGrowth -0.857
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins -16.36125
profitMargins 0.0
enterpriseValue 6.51M
forwardPE -0.3779221
floatShares 46.78M
sharesOutstanding 54.85M
sharesShort 609.72K
sharesShortPriorMonth 1.21M
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.16%
heldPercentInstitutions 0.33%
Short Ratio help_outline 1.94%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 0.211
Price To Book help_outline 1.38
earningsQuarterlyGrowth
netIncomeToCommon -111.08M
trailingEps -2.04%
forwardEps -0.77%
enterpriseToEbitda -0.06
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.25 3Q 2024
institutionsCount 102
lastUpdated Nov. 6, 2024, 5:23 p.m.